Genprex, Inc. (GNPX)

Trade GNPX now with
3/24/2020 8:24:46 AM Genprex Appoints Brent Longnecker, Jose Moreno Toscano And William Wilson To Board
3/23/2020 8:21:22 AM Genprex Appoints Catherine Vaczy As EVP And Chief Strategy Officer And Michael Redman As EVP And Chief Operating Officer
2/19/2020 9:25:24 AM Genprex Prices $17.50 Mln Common Stock Offering At-The-Market And Without Warrants
2/11/2020 10:00:35 AM Stock Alert: Genprex (GNPX)
2/11/2020 8:19:21 AM Genprex Signs Exclusive License Agreement With The University Of Pittsburgh For A Diabetes Gene Therapy
2/6/2020 8:22:18 AM Genprex Regains Compliance With Nasdaq Minimum Bid Price Requirement
1/28/2020 8:13:28 AM Genprex Reports Closing Of $8 Mln At-The-Market Common Stock Offering
1/23/2020 9:04:26 AM Genprex Prices $8 Mln Common Stock Offering Priced At-The-Market
1/21/2020 8:09:15 AM Genprex Receives FDA Fast Track Designation For Gene Therapy That Targets Lung Cancer
11/20/2019 11:54:04 AM Genprex Announces $1.26 Mln Registered Direct Offering
7/1/2019 8:44:25 AM Genprex Updates On Development Of Oncoprex Immunogene Therapy Plus Immunotherapy
10/30/2018 8:06:32 AM Genprex Appoints Jan Stevens As Vice President Of Clinical Operations